Posted on 08 December 2014
Biotech rumor mill: Helix BioPharma Corp. announced Friday that it has begun “a comprehensive exploration of growth opportunities,” code that most of the biotech market has taken to mean the company has a shopping list of potential acquisitions and will be buying snap-on targets soon.
Posted on 31 October 2014
Big pharma company Bayer , is going hunting for pharma deals again, with its chief executive expected to tell media outlets that it is looking for further takeover pharma deals.
Posted on 27 October 2014
Private equity firms are circling Bayer’s €10bn plastics business merger, hoping to divert the German drugmaker from its plan to list the division, two people familiar with the matter said yesterday.
Posted on 22 October 2014
Several companies are rumored to be competing to acquire Omega Pharma, the fastest growing consumer healthcare company in the U.K. and Ireland.
Posted on 16 October 2014
In response to recent changes to the U.S. tax code to discourage so-called tax inversion deals, Chicago-based AbbVie recently indicated it was rethinking its $54 billion takeover bid of U.K.-based Shire.
Posted on 15 October 2014
Actavis Plc plans to approach Allergan Inc again about a potential merger, as the Botox maker warms up to the possibility of a sale, people familiar with the matter said on Tuesday.
Posted on 06 October 2014
Arbor Pharmaceuticals LLC is allegedly exploring a potential acquisition and merger partner that could bring in more than $1 billion, according to people who are close to the situation.
Posted on 24 September 2014
Pfizer Inc. has approached Actavis with a possibility to acquire the company.
Posted on 15 September 2014
Akorn targets UCB‘s subsidiary for acquisition for tax inversion.
Posted on 01 September 2014
Belgium-based healthcare company Omega Pharma NV is allegedly attracting numerous bids from businesses across the big pharma companies, according to Bloomberg Businessweek. Perrigo and Boehringer Ingelheim GmbH are rumored to be interested in acquiring the company.